Sanara MedTech Inc. (SMTI)
USD 27.02
(-1.92%)
USD 27.02
(-1.92%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.3 Million USD | 46.82% |
| 2022 | -8.09 Million USD | -10.77% |
| 2021 | -7.3 Million USD | -66.69% |
| 2020 | -4.38 Million USD | -49.57% |
| 2019 | -2.93 Million USD | -387.9% |
| 2018 | -600.57 Thousand USD | -281.27% |
| 2017 | 331.3 Thousand USD | 179.69% |
| 2016 | -415.74 Thousand USD | 68.98% |
| 2015 | -1.34 Million USD | 41.16% |
| 2014 | -2.27 Million USD | 45.08% |
| 2013 | -4.14 Million USD | -124.79% |
| 2012 | -1.84 Million USD | 85.52% |
| 2011 | -12.74 Million USD | -148.09% |
| 2010 | -5.13 Million USD | -123.04% |
| 2009 | -2.3 Million USD | -29.85% |
| 2008 | -1.77 Million USD | -226.7% |
| 2007 | -542.75 Thousand USD | 12.96% |
| 2006 | -623.55 Thousand USD | 17.72% |
| 2005 | -757.86 Thousand USD | 87.96% |
| 2004 | -6.29 Million USD | 0.0% |
| 2001 | -1.52 Million USD | -38.87% |
| 2000 | -1.1 Million USD | -330.66% |
| 1999 | 477.58 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.76 Million USD | -643.77% |
| 2024 Q2 | -3.5 Million USD | -98.62% |
| 2023 Q3 | -1.06 Million USD | 41.98% |
| 2023 Q4 | -237.19 Thousand USD | 77.63% |
| 2023 FY | -4.3 Million USD | 46.82% |
| 2023 Q2 | -1.82 Million USD | -21.52% |
| 2023 Q1 | -1.5 Million USD | 87.16% |
| 2022 Q1 | -3.12 Million USD | 11.81% |
| 2022 Q2 | -3.24 Million USD | -3.71% |
| 2022 Q4 | -11.71 Million USD | -665.81% |
| 2022 Q3 | -1.52 Million USD | 52.88% |
| 2022 FY | -8.09 Million USD | -10.77% |
| 2021 Q2 | -1.17 Million USD | 0.87% |
| 2021 FY | -7.3 Million USD | -66.69% |
| 2021 Q3 | -2.02 Million USD | -72.46% |
| 2021 Q4 | -3.54 Million USD | -75.63% |
| 2021 Q1 | -1.18 Million USD | -379.42% |
| 2020 Q3 | -1.14 Million USD | -1.91% |
| 2020 Q2 | -1.12 Million USD | 38.72% |
| 2020 Q4 | -246.49 Thousand USD | 78.51% |
| 2020 FY | -4.38 Million USD | -49.57% |
| 2020 Q1 | -1.83 Million USD | -25.55% |
| 2019 Q2 | -351.41 Thousand USD | -116.16% |
| 2019 FY | -2.93 Million USD | -387.9% |
| 2019 Q4 | -1.46 Million USD | -74.81% |
| 2019 Q3 | -836.97 Thousand USD | -138.17% |
| 2019 Q1 | -162.57 Thousand USD | 66.61% |
| 2018 Q3 | -151.03 Thousand USD | -584.5% |
| 2018 Q2 | 31.17 Thousand USD | 402.06% |
| 2018 Q1 | 6209.00 USD | -97.49% |
| 2018 FY | -600.57 Thousand USD | -281.27% |
| 2018 Q4 | -486.92 Thousand USD | -222.4% |
| 2017 Q4 | 247.77 Thousand USD | 610.21% |
| 2017 Q1 | 53.05 Thousand USD | -77.42% |
| 2017 Q3 | -48.56 Thousand USD | -161.44% |
| 2017 Q2 | 79.04 Thousand USD | 48.97% |
| 2017 FY | 331.3 Thousand USD | 179.69% |
| 2016 Q3 | 181.48 Thousand USD | 119.67% |
| 2016 Q1 | 90.27 Thousand USD | 120.24% |
| 2016 Q2 | -922.43 Thousand USD | -1121.81% |
| 2016 FY | -415.74 Thousand USD | 68.98% |
| 2016 Q4 | 234.92 Thousand USD | 29.45% |
| 2015 Q2 | -582.32 Thousand USD | -336.53% |
| 2015 Q3 | -178.71 Thousand USD | 69.31% |
| 2015 FY | -1.34 Million USD | 41.16% |
| 2015 Q1 | -133.39 Thousand USD | 53.24% |
| 2015 Q4 | -446.02 Thousand USD | -149.58% |
| 2014 Q4 | -285.28 Thousand USD | 57.48% |
| 2014 Q3 | -671 Thousand USD | 13.52% |
| 2014 Q2 | -775.92 Thousand USD | -42.12% |
| 2014 Q1 | -545.96 Thousand USD | 63.26% |
| 2014 FY | -2.27 Million USD | 45.08% |
| 2013 Q3 | -1.68 Million USD | -5118.63% |
| 2013 Q2 | -32.33 Thousand USD | 96.57% |
| 2013 Q1 | -942.26 Thousand USD | -33.6% |
| 2013 FY | -4.14 Million USD | -124.79% |
| 2013 Q4 | -1.48 Million USD | 11.95% |
| 2012 FY | -1.84 Million USD | 85.52% |
| 2012 Q4 | -705.3 Thousand USD | 49.54% |
| 2012 Q3 | -1.39 Million USD | -4614.57% |
| 2012 Q2 | -29.65 Thousand USD | -110.31% |
| 2012 Q1 | 287.5 Thousand USD | 105.02% |
| 2011 Q1 | -2.74 Million USD | -78.05% |
| 2011 FY | -12.74 Million USD | -148.09% |
| 2011 Q4 | -5.73 Million USD | -437.69% |
| 2011 Q3 | -1.06 Million USD | 66.67% |
| 2011 Q2 | -3.19 Million USD | -16.58% |
| 2010 FY | -5.13 Million USD | -123.04% |
| 2010 Q1 | -1.24 Million USD | -0.92% |
| 2010 Q2 | -663 Thousand USD | 46.73% |
| 2010 Q3 | -1.68 Million USD | -154.19% |
| 2010 Q4 | -1.54 Million USD | 8.55% |
| 2009 Q2 | -323.91 Thousand USD | 36.4% |
| 2009 Q3 | -258.84 Thousand USD | 20.09% |
| 2009 Q1 | -509.25 Thousand USD | 39.73% |
| 2009 Q4 | -1.23 Million USD | -376.41% |
| 2009 FY | -2.3 Million USD | -29.85% |
| 2008 Q4 | -844.96 Thousand USD | -147.44% |
| 2008 Q2 | -233.5 Thousand USD | 33.89% |
| 2008 Q1 | -353.23 Thousand USD | -55.73% |
| 2008 FY | -1.77 Million USD | -226.7% |
| 2008 Q3 | -341.49 Thousand USD | -46.25% |
| 2007 Q2 | -16.15 Thousand USD | 90.68% |
| 2007 FY | -542.75 Thousand USD | 12.96% |
| 2007 Q4 | -226.82 Thousand USD | -79.27% |
| 2007 Q3 | -126.52 Thousand USD | -683.45% |
| 2007 Q1 | -173.25 Thousand USD | 15.53% |
| 2006 Q2 | -148.4 Thousand USD | -13.49% |
| 2006 Q1 | -130.76 Thousand USD | -18.02% |
| 2006 Q3 | -140.67 Thousand USD | 5.21% |
| 2006 Q4 | -205.1 Thousand USD | -45.8% |
| 2006 FY | -623.55 Thousand USD | 17.72% |
| 2005 FY | -757.86 Thousand USD | 87.96% |
| 2005 Q4 | -110.79 Thousand USD | 10.02% |
| 2005 Q2 | -344.58 Thousand USD | -94.68% |
| 2005 Q1 | -177 Thousand USD | 11.57% |
| 2005 Q3 | -123.12 Thousand USD | 64.27% |
| 2004 Q4 | -200.15 Thousand USD | 96.6% |
| 2004 FY | -6.29 Million USD | 0.0% |
| 2004 Q3 | -5.89 Million USD | -4909.85% |
| 2004 Q2 | -117.59 Thousand USD | -36.51% |
| 2004 Q1 | -86.14 Thousand USD | 0.0% |
| 2002 Q1 | -436.03 Thousand USD | 41.54% |
| 2001 Q4 | -745.86 Thousand USD | -27.28% |
| 2001 Q1 | -29.24 Thousand USD | 94.42% |
| 2001 FY | -1.52 Million USD | -38.87% |
| 2001 Q3 | -586 Thousand USD | -237.75% |
| 2001 Q2 | -173.5 Thousand USD | -493.31% |
| 2000 FY | -1.1 Million USD | -330.66% |
| 2000 Q2 | -332.76 Thousand USD | -1179.24% |
| 2000 Q3 | -218.94 Thousand USD | 34.21% |
| 2000 Q1 | -26.01 Thousand USD | 0.0% |
| 2000 Q4 | -523.89 Thousand USD | -139.29% |
| 1999 FY | 477.58 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 93.204% |
| AngioDynamics, Inc. | -184.34 Million USD | 97.666% |
| AtriCure, Inc. | -30.43 Million USD | 85.862% |
| Avinger, Inc. | -18.32 Million USD | 76.511% |
| Azenta, Inc. | -14.25 Million USD | 69.817% |
| BioLife Solutions, Inc. | -66.42 Million USD | 93.522% |
| The Cooper Companies, Inc. | 294.2 Million USD | 101.463% |
| Daxor Corporation | 280.64 Thousand USD | 1633.351% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 71.686% |
| Femasys Inc. | -14.24 Million USD | 69.796% |
| GlucoTrack, Inc. | -7.09 Million USD | 39.366% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -26.009% |
| Hologic, Inc. | 789.5 Million USD | 100.545% |
| ICU Medical, Inc. | -29.65 Million USD | 85.489% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.239% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 68.684% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 114.294% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 35.421% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 35.421% |
| Masimo Corporation | 81.5 Million USD | 105.28% |
| Microbot Medical Inc. | -10.74 Million USD | 59.933% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 137.015% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 104.558% |
| Nephros, Inc. | -1.57 Million USD | -173.219% |
| NovoCure Limited | -207.04 Million USD | 97.922% |
| NEXGEL, Inc. | -3.15 Million USD | -36.307% |
| NEXGEL, Inc. | -3.15 Million USD | -36.307% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 95.462% |
| OraSure Technologies, Inc. | 53.65 Million USD | 108.02% |
| Pro-Dex, Inc. | 2.12 Million USD | 302.313% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 89.805% |
| Predictive Oncology Inc. | -13.98 Million USD | 69.228% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -45.803% |
| QuidelOrtho Corporation | -10.1 Million USD | 57.394% |
| Repligen Corporation | 41.57 Million USD | 110.35% |
| STAAR Surgical Company | 21.34 Million USD | 120.158% |
| Sharps Technology, Inc. | -9.84 Million USD | 56.276% |
| Utah Medical Products, Inc. | 16.63 Million USD | 125.868% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 96.74% |
| Jin Medical International Ltd. | 2.87 Million USD | 249.508% |